Drug & medication recalls Moderate risk

AstraZeneca Pharmaceuticals LP recalls NEXIUM¿ (esomeprazole magnesium), Delayed-Release capsules, 20 mg, 30-count bottle, Rx only, Manufactured for AstraZene…

Recall date
June 10, 2015
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
D-1141-2015
FDA classification
Class II
Brand / firm
AstraZeneca Pharmaceuticals LP
Sold / distributed
Nationwide to wholesalers for further distribution at the retail level.

Why it was recalled

Presence of Foreign Tablets/Capsules: Confimed customer compliant by a retail pharmacist that an unopened bottle labeled as NEXIUM¿ capsules contained 60 SEROQUEL¿ XR tablets.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

NEXIUM¿ (esomeprazole magnesium), Delayed-Release capsules, 20 mg, 30-count bottle, Rx only, Manufactured for AstraZeneca LLC, Wilmington, Distributed by AstraZeneca, AB, Sodertalje, Sweden. NDC 00186-5020-31.

Get recall alerts

Free email alert whenever AstraZeneca Pharmaceuticals LP has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: AstraZeneca Pharmaceuticals LP